EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people

APMIS

Volumn 115, Issue 8, 2007, Pages 929-938

  Tsai, Wen Chiuan ^a   Chao, You Chen ^a   Sheu, Lai Fa ^a   Lin, Yeh Feng ^a   Nieh, Shin ^a   Chen, Ann ^a   Yu, Cheng Pin ^a   Jin, Jong Shiaw ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

EMMPRIN; Fascin; Immunostaining scores; Pancreatobiliary carcinoma; Survival test

Indexed keywords

CD147 ANTIGEN; FASCIN;

ADVANCED CANCER; ARTICLE; BILE DUCT CANCER; CANCER STAGING; CANCER SURVIVAL; CELL MEMBRANE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TISSUE SECTION;

ADENOCARCINOMA; ANTIGENS, CD147; BILIARY TRACT NEOPLASMS; CARRIER PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; NEOPLASM STAGING; PANCREATIC NEOPLASMS;

EID: 34547868109     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2007.apm_858.x     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007 57:43 66.
2. Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol 2005 29:359 67.
3. Yan L, Zucker S, Toole BP. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 2005 93:199 204.
4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000 100:57 70.
5. Guo H, Li R, Zucker S, Toole BP. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 2000 60:888 91.
6. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997 89:1260 70.
7. Nabeshima K, Suzumiya J, Nagano M, Ohshima K, Toole BP, Tamura K, et al. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol 2004 202:341 51.
8. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998 10:602 8.
9. Riethdorf S, Reimers N, Assmann V, Kornfeld JW, Terracciano L, Sauter G, et al. High incidence of EMMPRIN expression in human tumors. Int J Cancer 2006 119:1800 10.
10. Yamashiro-Matsumura S, Matsumura F. Intracellular localization of the 55-kD actin-bundling protein in cultured cells: spatial relationships with actin, alpha-actinin, tropomyosin, and fimbrin. J Cell Biol 1986 103:631 40.
11. Xie JJ, Xu LY, Zhang HH, Cai WJ, Mai RQ, Xie YM, et al. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 2005 337:355 62.
12. Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 2005 37:1787 804.
13. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004 16:590 6.
14. Fan G, Kotylo P, Neiman RS, Braziel RM. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease. Am J Clin Pathol 2003 119:199 204.
15. Grothey A, Hashizume R, Sahin AA, McCrea PD. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000 83:870 3.
16. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004 67:262 70.
17. Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003 88:537 47.
18. Roma AA, Prayson RA. Fascin expression in 90 patients with glioblastoma multiforme. Ann Diagn Pathol 2005 9:307 11.
19. Tong GX, Yee H, Chiriboga L, Hernandez O, Waisman J. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol 2005 36:741 6.
20. Hemilton SR, Aaltonen LA. WHO classification of tumors: tumors of the digestive system. Lyon:IRAC, 2000.
21. Greene FL, Page LD, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC Cancer Staging Manual. Sixth edition. Philadelphia:Springer, 2007.
22. Bhanot U, Heydrich R, Moller P, Hasel C. Survivin expression in pancreatic intraepithelial neoplasia (PanIN): steady increase along the developmental stages of pancreatic ductal adenocarcinoma. Am J Surg Pathol 2006 30:754 9.
23. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006 56:359 67.